| Line Item | 2026-02-28 | Y/Y |
|---|---|---|
| Revenue | $514K | -95.3% |
| Cost of Revenue | $381K | +74.8% |
| R&D Expense | $3.5M | -49.4% |
| SG&A Expense | $6.4M | -30.6% |
| Interest Expense | $1.7M | +175.6% |
| Pre-tax Income | -$12.3M | +18.3% |
| Income Tax | $0 | — |
| Net Income | -$12.3M | +18.3% |
| EPS (Basic) | -$0.26 |
| Line Item | 2026-02-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.4M | -81.8% |
| Accounts Receivable | $755K | +18.2% |
| Inventory | $0 | -100.0% |
| Current Assets | $3.6M | -74.0% |
| Total Assets | $8.6M | -53.9% |
| Current Liabilities | $2.8M | -30.4% |
| Long-term Debt | $3.1M | -2.7% |
| Line Item | 2026-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.1M | -376.7% |
| Investing Cash Flow | -$1.2M | +42.5% |
| Financing Cash Flow | $678K | -93.4% |
| +18.8% |
| Total Liabilities |
| $18.1M |
| -0.4% |
| Stockholders' Equity | -$9.6M | -2710.4% |